EVH - Evolent Health, Inc.

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 26.96

Open

$ 27.15

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 26.86 - $ 27.33

52 Week Range

$ 23.33 - $ 35.83

Volume

1,608,589

Average Volume

Market Cap

Beta (5Y Monthly)

$ 1.25

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-23-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-02-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	02-24-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-03-2022	06-30-2022	10-Q
8	05-04-2022	03-31-2022	10-Q
9	02-23-2022	12-31-2021	10-K
10	11-03-2021	09-30-2021	10-Q
11	08-04-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-26-2021	12-31-2020	10-K
14	11-06-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-28-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-05-2019	09-30-2019	10-Q
19	08-09-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	02-28-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-01-2018	12-31-2017	10-K
26	11-09-2017	09-30-2017	10-Q
27	08-07-2017	06-30-2017	10-Q
28	05-10-2017	03-31-2017	10-Q
29	03-03-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	05-16-2016	03-31-2016	10-Q
33	02-29-2016	12-31-2015	10-K
34	11-06-2015	09-30-2015	10-Q
35	08-07-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evolent And Careology Form Partnership To ...
05/09/2024 21:35:48

Digital cancer care platform Careology and Evolent (NYSE:EVH) to offer an innovative platform to enable cancer navigationEvolen...

Evolent Health Sees Q2 Revenue $625M-$645M...
05/09/2024 20:24:04

Second Quarter 2024 GuidanceFor the three months ended June 30, 2024, revenue is expected to be in the range of approximately $...

Evolent Health Q1 Adj $0.34 Beats $0.24 Es...
05/09/2024 20:10:57

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.24 by ...

In-Depth Examination Of 6 Analyst Recommen...
04/22/2024 20:02:01

Citigroup Initiates Coverage On Evolent He...
04/22/2024 12:57:32

Citigroup analyst Daniel Grosslight initiates coverage on Evolent Health (NYSE:EVH) with a Buy rating and announces Price Ta...

Canaccord Genuity Maintains Buy on Evolent...
03/28/2024 11:27:57

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $45 ...

Navigating 4 Analyst Ratings For Evolent H...
03/15/2024 16:00:26

JP Morgan Maintains Overweight on Evolent ...
03/15/2024 14:17:35

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $53 to ...

Oppenheimer Initiates Coverage On Evolent ...
03/01/2024 12:59:24

Oppenheimer analyst Jeff Jones initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price ...

these-analysts-revise-their-forecasts-on-evolent-health-after-upbeat-results

These Analysts Revise Their Forecasts On E...
02/23/2024 19:31:29

Evolent Health, Inc. (NYSE: EVH) reported better-than-expected fourth-quarter results on Thursday.

why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Why MercadoLibre Shares Are Trading Lower ...
02/23/2024 19:07:11

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

Analyst Scoreboard: 4 Ratings For Evolent ...
02/23/2024 18:01:26

JMP Securities Maintains Market Outperform...
02/23/2024 17:34:10

JMP Securities analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and raises the price...

Canaccord Genuity Maintains Buy on Evolent...
02/23/2024 14:40:57

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $47 ...

Evolent Health Q4 EPS $0.23 Beats $0.15 Es...
02/22/2024 21:45:25

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.15 by ...

Evolent Health Q4 Sales $556.05M Beat $542...
02/22/2024 21:36:21

Evolent Health (NYSE:EVH) reported quarterly sales of $556.05 million which beat the analyst consensus estimate of $542.40 mill...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
02/22/2024 21:31:07

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Evolent Health's Earnings: A Preview
02/21/2024 15:01:01

Analyst Expectations for Evolent Health's ...
12/06/2023 13:00:40

IPO Investing: Understanding The Crumbling...
01/11/2016 19:34:56